CONGRESSMAN CICILLINE BECOMES MEMBER OF CONGRESSIONAL TASK FORCE ON ALZHEIMER’S DISEASE

Monday, March 11, 2019

PROVIDENCE – Congressman David Cicilline has joined his colleague James Langevin in the House of Representatives as the newest member of the Congressional Task Force on Alzheimer’s disease, which was established 20 years ago to advance research and public awareness of Alzheimer’s disease by bringing the disease to the forefront of the congressional agenda.  

 

“Alzheimer’s Disease is among the most serious growing health threats in America, and especially right here in Rhode Island where it is one of the top causes of death,” said Congressman Cicilline. “I’m proud to join the Congressional Task Force on Alzheimer’s Disease to continue our state’s leadership in Alzheimer’s research and awareness.  While our delegation has done so much work at the federal level to make sure the NIH has the necessary resources to fight back against this disease, it’s clear that more work needs to be done. I look forward to continuing this fight alongside my colleagues on the task force and friends at the Alzheimer’s Association, who have been such crucial partners every step of the way.”

 

This important step by Congressman Cicilline further puts Rhode Island at the forefront of trying to address the massive issues surrounding the disease, which is the 5th leading cause of death in the state.

 

“Our federal legislators are increasingly making research, care and support for Alzheimer’s disease a priority; from the development of the National Alzheimer’s Plan in 2012 to the passage of a $100 million increase in Federal funding through the passage of the BOLD Act in 2018,” said Donna M. McGowan, Executive Director of the Alzheimer’s Association, Rhode Island Chapter. “Having another one of our own in Washington take a leadership role in this fight by joining the task force shows the commitment to address this public health crisis. On its current trajectory, Alzheimer’s disease will be the leading cause of death by 2050.”

 

In the 116th Congress the bipartisan task force is led by House Co-Chairs Representative Maxine Waters (D-CA-43), Representative Christopher H. Smith (R-NJ-4) and Senate Co-Chairs Senator Susan Collins (R-ME), Senator Mark Warner (D-VA), Senator Ed Markey (D-MA) and Senator Pat Toomey (R-PA). The more than 150 members of the Task Force and their influence have been instrumental in helping the more than 5 million Americans living with Alzheimer’s disease.

The Congressional Task Force on Alzheimer’s Disease, with the support of the Alzheimer’s Association, worked to unanimously pass the National Alzheimer’s Project Act (PL-111-375) and the BOLD Act, among other key legislation. The Task Force has also been instrumental in securing funding for research at the National Institutes of Health and raising awareness of this disease through congressional briefings and other events featuring award-winning researchers.

 

About the Alzheimer’s Association

The Alzheimer’s Association is the world’s leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer’s. Visit www.alz.org or call 800.272.3900.

JOIN THE TEAM

DNC Twitter